Precipio, Inc. — Director's Dealing 2012

Feb 7, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRANSGENOMIC INC (TBIO.OB)
CIK: 0001043961
Period of Report: 2012-02-03

Reporting Person: Koppler Doit II (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-02-03	Common Stock	P	35000	—	Acquired	50000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-02-03	Warrant to Purchase Shares of Common Stock	$1.25	A	17500	Acquired	2017-02-02	Common Stock (17500)	Direct

Footnotes

F1: Mr. Koppler purchased 35,000 Units for $1.00 per Unit. Each Unit consists of one (1) share of Common Stock and a Warrant to Purchase 0.5 shares of Common Stock at an exercise price of $1.25 per share.

F2: These warrants are exercisable immediately upon issuance.